TY - JOUR
AU - Landewé, Robert B.M.
AU - Kroon, Féline P.B.
AU - Alunno, Alessia
AU - Najm, Aurélie
AU - Bijlsma, Johannes W.J.
AU - Burmester, Gerd R.
AU - Caporali, Roberto
AU - Combe, Bernard
AU - Conway, Richard
AU - Curtis, Jeffrey R.
AU - Elkayam, Ori
AU - Gossec, Laure
AU - Heijstek, Marloes W.
AU - Haupt, Lukas
AU - Iagnocco, Annamaria
AU - Isaacs, John D.
AU - Juhász, István Ábel
AU - Makri, Suzi
AU - Mariette, Xavier
AU - McInnes, Iain B.
AU - Mehta, Puja R.
AU - Mueller-Ladner, Ulf
AU - Schulze-Koops, Hendrik
AU - Smolen, Josef S.
AU - Wiek, Dieter
AU - Winthrop, Kevin L.
AU - Navarro-Compán, Victoria
AU - Machado, Pedro M.
PY - 2022
DA - February
TI - EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
JO - Annals of the Rheumatic Diseases
DO - http://dx.doi.org/10.1136/annrheumdis-2021-222006
AB - The first EULAR provisional recommendations on the management of rheumatic and musculoskeletal diseases (RMDs) in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), largely based on expert opinion, were published in June 2020. Since then, an unprecedented number of clinical studies have accrued in the literature. Several SARS-CoV-2 vaccines have been approved for population-wide vaccination programmes in EULAR-affiliated countries. Studies regarding vaccination of patients with (inflammatory) RMDs have released their first results or are underway.
PB - BMJ Publishing Group
UR - http://eprints.gla.ac.uk/266865/
KW - Coronavirus (COVID-19)
ER